An interventional study of skin to skin care and Standard Care (in control arm) in Effect of Skin to Skin Care in Preterm Neonates and Skin to Skin Care, sponsored by Medical University of Graz. Recruiting at 1 site in Austria. Open to participants aged 0 Minutes to 30 Minutes. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Medical University of Graz · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The standard procedure in our centre for preterm neonates is to enable skin-to-skin (SSC) contact within 24 hours after birth. As early SSC immediately after birth might provide numerous positive effects for mothers and their preterm neonates, the objective of this study is to evaluate the feasibility, the safety and the effect of skin-to-skin contact immediately after birth in preterm neonates born with gestational age between 26+0 and 32+0 weeks.
Medical University of Graz is the lead sponsor of 471 studies on the registry; 98 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention group
Procedure: skin to skin care
Control group
Procedure: Standard Care (in control arm)
skin to skin care of preterm infants with their parents immediately after birth
skin to skin care within 24 hours after birth
vital parameter: Heart rate
Time frame: during the first 2 hours after birth
vital parameter: Oxygen saturation
in percent
Time frame: during the first 2 hours after birth
vital parameter: blood pressure
systolic, diastolic and mean blood pressure
Time frame: during the first 2 hours after birth
vital parameter: Temperature
Time frame: during the first 2 hours after birth
blood sugar
capillary blood sugar measured 1 hour after birth
Time frame: 1 hour after birth
FiO2 (Fraction of inspired oxygen)
Need of oxygen
Time frame: during first 2 hours after birth
Plan to share: No — It is single center study
No publications or documents are linked to this record.
Started Feb 2025 (actual). Primary completion is estimated for Feb 2027, 24 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.